drugset / Trial / NCT00190749
Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will assess whether olanzapine and/or risperidone affect the way the human body uses sugar in the blood.
Timeline
- Start
- 2003-10
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 5 mg | Oral |
| Subject | Olanzapine | Small molecule | 20 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 2 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 6 mg | Oral |